Trials / Sponsors / Integro Theranostics
Integro Theranostics
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for P Non Small Cell Lung Cancer (NSCLC) | Phase 2 | 2025-12-08 |
| Active Not Recruiting | A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Int Lung Cancers | Phase 1 | 2024-11-07 |
| Active Not Recruiting | LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive B Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast | Phase 1 / Phase 2 | 2023-07-14 |